CCND1 and endometrial cancer: Furthermore, mutations within the coding region of cyclin D1, found in cases of esophageal and endometrial cancer (Moreno-Bueno et al, 2003; Benzeno et al, 2006), have yet to be associated with clinical markers of disease progression, together suggesting that the observed oncogenic functions of cyclin D1 involve additional mechanisms of deregulation.